Biotech M&A, Earnings to Rise, Werber Says

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

Nov. 5 (Bloomberg) -- Yaron Werber, biotechnology analyst at Citigroup Inc., talks with Bloomberg Industries senior healthcare analyst Andrew Berens and Bloomberg's Sasha Damouni about the biotechnology industry and the outlook for earnings and mergers and acquisitions. (This is an excerpt. Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change